[ 메디채널 김갑성 기자 ] Uniting Global Proton Therapy Leaders to Advance Precision Cancer Treatment HONG KONG, Nov. 13, 2025 -- Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November 2025. Marking the first-ever landmark particle therapy academic conference in Hong Kong, the PTCOG-AO 2025 Conference attracted close to 600 participants from 16
BANGKOK, Nov. 13, 2025 -- MP Group (Thailand) Co., Ltd., a pioneering force in the Thai healthcare ecosystem, was proudly honored with the Corporate Excellence Award at the Asia Pacific Enterprise Awards (APEA) Thailand Chapter, organized by Enterprise Asia. This accolade celebrates the company's remarkable journey, marked by two decades of unwavering commitment to medical innovation, holistic wellness, and empowering the community to "Live An Excellent Life." Founded in 2001, MP Group began as a distributor of medical diagnostic devices and has since evolved into a comprehen
BANGKOK, Nov. 13, 2025 -- The journey of Mr. Sara Lamsam, CEO of Muang Thai Life Assurance (MTL), is a testament to the power of fusing strategic leadership with digital innovation. His success has been recognized with the Master Entrepreneur Award at the Asia Pacific Enterprise Awards (APEA) Thailand organised by Enterprise Asia, while his transformative work at the company earned MTL the Corporate Excellence Award. With over 32 years of experience and a strong belief in continuous self-development, Sara has spent his career modernizing the insurance industry. He spearheaded the cruci
Report highlights emerging biotech innovators advancing new therapies, equity and investment across reproductive, chronic and mental health LONDON, Nov. 13, 2025 -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its latest Companies to Watch report, Rediscovering Women's Health, highlighting seven companies driving innovation across reproductive care, chronic disease and mental health. Drawing on proprietary data, expert analysis and insights into therapeutic impact, financing activity and R&D momentum, the report showca
CHIANG MAI, Thailand, Nov. 13, 2025 -- A major step forward in regional collaboration for cancer care was announced today with the launch of Project ACTIVE 2.0 (Advancing Cervical Cancer Treatment & Patient Recovery Across Southeast Asia), a multi-country initiative that aims to strengthen radiation oncology services and improve outcomes for cervical cancer across Southeast Asia. This effort is backed by the German Federal Ministry of Economic Cooperation and Development - BMZ, DEG Impulse, the Embassy of the Federal Republic of Germany in Bangkok, Elekta, and the Federatio
XI'AN, China, Nov. 13, 2025 -- Guangzhou Focus Biotechnology Co., Ltd., a subsidiary of KHB Group and an innovator in veterinary point-of-care testing (POCT) solutions, presents the enhanced FOCUS PEGASUS MF200 Automatic Multifunctional Veterinary Analyzer — a next-generation system that redefines efficiency, reliability, and accessibility in veterinary diagnostics. The MF200 integrates Biochemistry, Electrolytes, Coagulation, and Immunofluorescence testing into one compact analyzer — delivering smart point-of-care diagnostics that meet the demands of modern veterinary practice
FC Barcelona Striker Partners with Most Clinically Researched Ashwagandha Brand, KSM-66 LOS ANGELES, Nov. 13, 2025 -- KSM-66®, one of the world's largest natural product ingredient brands and best-selling ashwagandha extract, today announced Robert Lewandowski as its global brand ambassador. The FC Barcelona striker and Poland captain will represent the brand worldwide across all markets where KSM-66 operates. The partnership pairs Lewandowski's two-decade career at football's elite level with KSM-66 Ashwagandha's commitment to 4000 year old Ayurvedic traditi
TOKYO, Nov. 13, 2025 -- HOTEL de DOCTOR 24, a specialized online medical consultation service provided by M3 Career, Inc., offers seamless 24-hour access to healthcare for international travelers facing difficulties obtaining medical care in Japan. While HOTEL de DOCTOR 24 has been available in Japan since April 2025 -- and already used by travelers from Singapore -- this marks the first official introduction of the service to the Singapore market, ensuring that future visitors can access trusted medical support during their stay in Japan. Image: https://cdn.kyodonewsprwire.jp/prwfile/
[ 메디채널 김갑성 기자 ] Research focuses on human cardiac organoids to uncover metabolic drivers of heart failure and accelerate new therapeutic strategies to improve cardiovascular outcomes SINGAPORE, Nov. 13, 2025 -- Agilent Technologies Inc. (NYSE: A) announced the signing of a five-year Memorandum of Understanding (MOU) with National Heart Centre Singapore (NHCS) to accelerate innovation in metabolic heart failure research, one of the most complex and underserved areas in cardiovascular medicine. Agilent Seahorse XF Flex Analyzer 3D Workflow Features Metabolic Profile
[ 메디채널 김갑성 기자 ] - 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 13, 2025 -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue of KRW 10.8 billion, operating profit of KRW 1.0 billion, and net profit of KRW 1.0 billion. Revenue rose approximately 58% year-on-year (YoY) from KRW 6.9 billion in the same period last year and 17% quarter-on-quarter (QoQ) from KRW 9.3 billion in Q2. With this, VUNO has achieved 11 consecutive